Parathyromatosis and Parathyroid Cancer

Part of the Cancer Treatment and Research book series (CTAR, volume 153)


Parathyroid carcinoma is a rare entity, accounting for less than 1% of all cases of primary hyperparathyroidism [1–5]. This chapter provides an overview of the clinical presentation, pathophysiology, and medical and surgical management of parathyroid carcinoma and highlights some of the ongoing controversies and areas of current research interest involving this uncommon disease, including: difficulties in distinguishing benign from malignant disease both macroscopically and histologically; recent developments in the understanding of the genetic basis for this disease; the use of calcimimetics and other medical therapies for nonoperative management; and the utility of multiple reoperations in patients with recurrent disease. This chapter also summarizes the current state of knowledge regarding parathyromatosis, defined as an overgrowth of multiple hyperfunctioning nodules of the parathyroid tissue, a condition which may develop after capsular fracture and intraoperative seeding during parathyroid tumor resection.


  1. 1.
    Sandelin K (2005) Parathyroid carcinoma. In: Clark OH (ed) Textbook of endocrine surgery, 2nd edn. Elsevier Saunders, Philadelphia, pp 549–554Google Scholar
  2. 2.
    Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM (2007) Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109:1736–1741CrossRefPubMedGoogle Scholar
  3. 3.
    Shane E (2001) Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab 86:485–493CrossRefPubMedGoogle Scholar
  4. 4.
    Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726CrossRefPubMedGoogle Scholar
  5. 5.
    Kebebew E (2001) Parathyroid carcinoma. Curr Treat Options Oncol 2:347–354CrossRefPubMedGoogle Scholar
  6. 6.
    Iihara M, Okamoto T, Suzuki R et al (2007) Functional parathyroid carcinoma: long-term treatment outcome and risk factor analysis. Surgery 142:936–943; discussion 43 e1Google Scholar
  7. 7.
    Obara T, Okamoto T, Kanbe M, Iihara M (1997) Functioning parathyroid carcinoma: clinicopathologic features and rational treatment. Semin Surg Oncol 13:134–141CrossRefPubMedGoogle Scholar
  8. 8.
    Favia G, Lumachi F, Polistina F, D’Amico DF (1998) Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg 22:1225–1230CrossRefPubMedGoogle Scholar
  9. 9.
    Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88:223–228CrossRefPubMedGoogle Scholar
  10. 10.
    Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538–544Google Scholar
  11. 11.
    Kebebew E (2008) Parathyroid carcinoma, a rare but important disorder for endocrinologists, primary care physicians, and endocrine surgeons. Thyroid 18:385–386CrossRefPubMedGoogle Scholar
  12. 12.
    Fernandez-Ranvier GG, Jensen K, Khanafshar E et al (2007) Nonfunctioning parathyroid carcinoma: case report and review of literature. Endocr Pract 13:750–757PubMedGoogle Scholar
  13. 13.
    Agarwal G, Dhingra S, Mishra SK, Krishnani N (2006) Implantation of parathyroid carcinoma along fine needle aspiration track. Langenbecks Arch Surg 391:623–626CrossRefPubMedGoogle Scholar
  14. 14.
    Lee JA, Inabnet WB 3rd (2005) The surgeon’s armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol 89:130–135CrossRefPubMedGoogle Scholar
  15. 15.
    Arici C, Cheah WK, Ituarte PH et al (2001) Can localization studies be used to direct focused parathyroid operations? Surgery 129:720–729CrossRefPubMedGoogle Scholar
  16. 16.
    Yen TW, Wang TS, Doffek KM, Krzywda EA, Wilson SD (2008) Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery 144:611–619; discussion 9–21Google Scholar
  17. 17.
    Kebebew E, Arici C, Duh QY, Clark OH (2001) Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg 136:878–885CrossRefPubMedGoogle Scholar
  18. 18.
    Placzkowski K, Christian R, Chen H (2007) Radioguided parathyroidectomy for recurrent parathyroid cancer. Clin Nucl Med 32:358–360CrossRefPubMedGoogle Scholar
  19. 19.
    Clark P, Wooldridge T, Kleinpeter K, Perrier N, Lovato J, Morton K (2004) Providing optimal preoperative localization for recurrent parathyroid carcinoma: a combined parathyroid scintigraphy and computed tomography approach. Clin Nucl Med 29:681–684CrossRefPubMedGoogle Scholar
  20. 20.
    Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R (2004) Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer 100:900–905CrossRefPubMedGoogle Scholar
  21. 21.
    Wiseman SM, Rigual NR, Hicks WL Jr et al (2004) Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J 83:491–494PubMedGoogle Scholar
  22. 22.
    Fernandez-Ranvier GG, Khanafshar E, Jensen K et al (2007) Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110:255–264CrossRefPubMedGoogle Scholar
  23. 23.
    Lumachi F, Basso SM, Basso U (2006) Parathyroid cancer: etiology, clinical presentation and treatment. Anticancer Res 26:4803–4807PubMedGoogle Scholar
  24. 24.
    Chang YJ, Mittal V, Remine S et al (2006) Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma. Am Surg 72:419–426PubMedGoogle Scholar
  25. 25.
    Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724–731CrossRefPubMedGoogle Scholar
  26. 26.
    Kameyama K, Takami H (2005) Proposal for the histological classification of parathyroid carcinoma. Endocr Pathol 16:49–52CrossRefPubMedGoogle Scholar
  27. 27.
    Stojadinovic A, Hoos A, Nissan A et al (2003) Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol 34:54–64CrossRefPubMedGoogle Scholar
  28. 28.
    Cryns VL, Thor A, Xu HJ et al (1994) Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 330:757–761CrossRefPubMedGoogle Scholar
  29. 29.
    Farnebo F, Auer G, Farnebo LO et al (1999) Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease. World J Surg 23:68–74CrossRefPubMedGoogle Scholar
  30. 30.
    Tahara H, Smith AP, Gaz RD, Arnold A (1996) Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocrinol Metab 81:3663–3667CrossRefPubMedGoogle Scholar
  31. 31.
    Shattuck TM, Valimaki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722–1729CrossRefPubMedGoogle Scholar
  32. 32.
    Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ (2005) One stage treatment of parathyroid cancer. Eur J Surg Oncol 31:78–83CrossRefPubMedGoogle Scholar
  33. 33.
    Iacobone M, Ruffolo C, Lumachi F, Favia G (2005) Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg 390:385–390CrossRefPubMedGoogle Scholar
  34. 34.
    Dotzenrath C, Goretzki PE, Sarbia M, Cupisti K, Feldkamp J, Roher HD (2001) Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease. Eur J Surg Oncol 27:383–389CrossRefPubMedGoogle Scholar
  35. 35.
    Sheehan JJ, Hill AD, Walsh MF, Crotty TB, McDermott EW, O’Higgins NJ (2001) Parathyroid carcinoma: diagnosis and management. Eur J Surg Oncol 27:321–324CrossRefPubMedGoogle Scholar
  36. 36.
    Bukowski RM, Sheeler L, Cunningham J, Esselstyn C (1984) Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med 144:399–400CrossRefPubMedGoogle Scholar
  37. 37.
    Bilezikian JP (1992) Management of acute hypercalcemia. N Engl J Med 326:1196–1203CrossRefPubMedGoogle Scholar
  38. 38.
    Phitayakorn R, McHenry CR (2008) Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J Am Coll Surg 206:1106–1115CrossRefPubMedGoogle Scholar
  39. 39.
    Block GA, Martin KJ, de Francisco AL et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525CrossRefPubMedGoogle Scholar
  40. 40.
    Szmuilowicz ED, Utiger RD (2006) A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy. Nat Clin Pract Endocrinol Metab 2:291–296; quiz 7Google Scholar
  41. 41.
    Silverberg SJ, Rubin MR, Faiman C et al (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808CrossRefPubMedGoogle Scholar
  42. 42.
    Calandra DB, Chejfec G, Foy BK, Lawrence AM, Paloyan E (1984) Parathyroid carcinoma: biochemical and pathologic response to DTIC. Surgery 96:1132–1137PubMedGoogle Scholar
  43. 43.
    Chahinian AP, Holland JF, Nieburgs HE, Marinescu A, Geller SA, Kirschner PA (1981) Metastatic nonfunctioning parathyroid carcinoma: ultrastructural evidence of secretory granules and response to chemotherapy. Am J Med Sci 282:80–84CrossRefPubMedGoogle Scholar
  44. 44.
    Munson ND, Foote RL, Northcutt RC et al (2003) Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 98:2378–2384CrossRefPubMedGoogle Scholar
  45. 45.
    Kleinpeter KP, Lovato JF, Clark PB et al (2005) Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol 12:260–266CrossRefPubMedGoogle Scholar
  46. 46.
    Fitko R, Roth SI, Hines JR, Roxe DM, Cahill E (1990) Parathyromatosis in hyperparathyroidism. Hum Pathol 21:234–237CrossRefPubMedGoogle Scholar
  47. 47.
    Matsuoka S, Tominaga Y, Sato T et al (2007) Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 31:299–305CrossRefPubMedGoogle Scholar
  48. 48.
    Kollmorgen CF, Aust MR, Ferreiro JA, McCarthy JT, van Heerden JA (1994) Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. Surgery 116:111–115PubMedGoogle Scholar
  49. 49.
    Tublin ME, Yim JH, Carty SE (2007) Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings. J Ultrasound Med 26:847–851PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Surgery, Section of Endocrine Surgery, Mt. Zion Medical CenterUniversity Of California San FranciscoSan FranciscoUSA

Personalised recommendations